European
AIDS Treatment
Group

EATG endorses the EU4Health Civil Society Alliance manifesto for the European election in 2024, gathering the support of more than 30 health civil society organisations. The manifesto defines priorities and recommendations ahead of the upcoming European elections in 2024, with the overarching goal of securing health on the EU political agenda

EATG endorses EACS statement calling on President Museveni and the Uganda Government to repeal the anti-homosexuality law

This year, EATG’s annual General Assembly (GA), was held online during the last weekend of May (26-27). After a long time, the GA took place in spring again instead of autumn, only a few months after the previous one.

After a successful period of online courses, the STEP-UP 2022/2023 participants are finally meeting face-to-face for the Community of Practice Workshop and networking weekend in Porto, Portugal.

A European Community Advisory Board (ECAB) online meeting between members from EATG and Merck Sharp and Dohme will be held on the 27th of June to discuss HPV vaccine efficacy and safety data, delivery and R&D.

On the 11th of May, the Thematic Network on HIV, TB, viral hepatitis and STIs of the EU Health Policy Platform released a Joint Statement which aims to bring attention to stakeholder priorities in EU policy and lead to follow-up actions.

Today we are launching the European AIDS Treatment Group Annual Report for 2022. Check out our activities during this year in review: achievements in numbers, reporting from our programmes, policy and advocacy, monthly highlights, figures for finances and membership and updates on communication and governance at a glance.

STEP-UP MOOC is in full swing now and more than 160 trainees have signed up and followed the online course. Do you want to know more about what’s inside the box? Here we are sharing information about our expert trainers and the diverse topics they cover.

On International Day Against Homophobia, Biophobia, & Transphobia, EATG endorses this important initiative by MPact & GATE aiming to advance structural change and meaningful investment in our communities’ health. 

On April 19th 2023, the EATG team met face-to-face with the members of the Community Advisory Panel (CAP) for the RBDCOV project in Girona, Spain.

After the end-of-project meeting that took place in Brussels at Hotel Le Plaza on Tuesday 25 April, today marks the official end of the EU-PEARL, a project thinking outside of the box and aiming to shape the future of clinical trials through Integrated Research Platforms (IRPs).

The European AIDS Treatment Group, along with European and local organisations came together to jointly organise and to invite you to a community e-meeting “Developments in PrEP Implementation Issues – an Update for Community Educators and Advocates”

The European AIDS Treatment Group, along with European and local organisations came together to jointly organise and to invite you to a community e-meeting “Developments in the HIV and STIs Biomedical Prevention Pipeline – An Update for Community Educators and Advocates”

This year, EATG’s annual General Assembly takes place virtually on 26-27 May. We are taking stock of achievements and challenges from the previous 12 months as well as we are voting and deciding on our next steps and representation in the EATG bodies.  

The International Coalition of Older People with HIV (iCOPe HIV) is pleased to invite you to join us at one of two upcoming virtual stakeholder meetings on setting global priorities regarding HIV and ageing.

EATG endorses this EUHPP Joint Statement calling for a Mental Health in All Policies (MHiaP) approach, i.e., for public policies across sectors to promote population mental health and wellbeing by initiating and facilitating action within different non-health public policy areas. The MHiAP approach emphasises the impacts of public policies on mental health determinants, strives to reduce mental health inequities, aims to highlight the opportunities offered by mental health to different policy areas, and reinforces the accountability of policymakers for mental health impacts.

EATG endorses the Joint Statement of the European Union (EU) Health Policy Platform Thematic Network* 2022-23, Navigating Health Inequalities in the EU through Artificial Intelligence (AI), published on Wednesday 19 April 2023. It focuses on actions needed to benefit from the potential of AI in health while protecting key populations.

In April 2023 DisQo published a Joint Statement with five key priorities calling for action against racism and discrimination to achieve health equity in a constructive, respectful, and participatory way. EATG endorses DisQo’s Joint Statement.

In this virtual event EATG presents their position paper and, through a roundtable discussion with three guest speakers, we address the importance, the barriers and next steps needed to include people living with HIV in clinical research of potentially life-extending or life-saving drugs and treatments for other health conditions and comorbidities.

The EU Health Policy Platform Annual Meeting that will be held on 19 April. The morning session is dedicated to the presentation of the Joint Statements by its Thematic Network leaders, followed by a roundtable to share the lessons learned and possible improvements for next cycles. The afternoon session is dedicated to the first results of the study assessing the EU Health Policy Platform.

Today, the European AIDS Treatment Group (EATG) and Alliance for Public Health (APH) launch the STEP-UP Massive Open Online Course platform. This free bilingual course is now open for registration.

Today, EATG and APH are glad to announce the launch of the STEP-UP MOOC platform. The STEP-UP MOOC (Massive Open Online Course) is a bilingual (English/Russian), self-paced e-learning training programme accessible to all participants, with no selection process mandated.

On Thursday 30th of March, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended authorising HIPRA’s COVID-19 vaccine, BIMERVAX®, as a booster in people aged 16 years and above who have been vaccinated with a COVID-19 mRNA vaccine.

EATG shares response to the European Commission consultation on the proposal for a Council Recommendation on vaccine-preventable cancers